Global Organ-On-Chip Market, By Organ Type (Liver, Heart, Lung, Other Organ Types), Application (Drug Discovery, Toxicology Research, Others), End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Other) - Industry Trends and Forecast to 2029
Market Analysis and Size
Researchers have been deploying a combination of labs-on-chips (LOCs) and cell biology to examine human physiology in an organ-specific environment over the years. This results in the emergence of new model of in vitro multicellular human organisms.
The organ-on-chip market was valued at USD 57.05 million in 2021 and is expected to reach USD 144.31 million by 2029, registering a CAGR of 12.30% during the forecast period of 2022-2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, import/export analysis, pricing analysis, production consumption analysis, and pestle analysis.
Market Definition
The organ-on-chip market comprises of sales of organs-on-chips by entities that manufacture organs-on-chips for drug development, toxicity testing, and personalized medicine research (organizations, lone traders, and partnerships). Organs-on-chips (OOCs) are small plastic devices with biocompatible microfluidic chambers that hold a 3D culture of numerous living human cells that mimic important physiological processes of body organs.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014- 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Organ Type (Liver, Heart, Lung, Other Organ Types), Application (Drug Discovery, Toxicology Research, Others), End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Other)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, Israel, Egypt, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
AxoSim (US), BiomimX S.r.l. (Italy), Elveflow (France), Emulate, Inc. (US), Hµrel Corporation (US), InSphero (Switzerland), MIMETAS (Netherlands), NORTIS, INC. (US), TARA Biosystems, Inc. (US), and Logo TissUse GmbH (Germany), among others
|
|
Market Opportunities
|
|
Organ-On-Chip Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints and challenges. All of this is discussed in detail as below:
Drivers
- Increase in Research Activities
The organ-on-chip industry is encouraged by determinants, such as a demand for substitutes for animal experimentation, the requirement for the initial discovery of remedy toxicity, and unique product launch and elevations in technology are also accountable for stimulating the market.
- Initiatives by Pharmaceutical Companies
The growing efforts by pharmaceutical corporations to finance and examine medication repurposing using organ-on-chip patterns, are also foreseen to push the increment of the organ-on-chip business.
- Integration of Technologies
The increase in demand for organ-on-chip as it combines tissue engineering and microfluidics. These technologies offer effective answers to long standing issues in individualized disease treatment and medication discovery. The technology assist in drug development studies.
Additionally, rapid urbanization, lifestyle change, investments, and increased consumer spending positively impact the organ-on-chip market.
Opportunities
Furthermore, an increase in need for personalized medicine extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Also, widespread employment of organ-on-chip surpassing the medical enterprise will further expand the market.
Restraints/Challenges
On the other hand, high cost associated with the organ chip device and the development of organ-on-chip (OOC) technology are expected to obstruct market growth. Also, stringent regulations are projected to challenge the organ-on-chip market in the forecast period of 2022-2029.
This organ-on-chip market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on organ-on-chip market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Covid-19 Impact on Organ-On-Chip Market
The COVID-19 had a negative impact on the organ-on-chip market owing to the strict lockdowns and social distancing to contain the spread of the virus. The economic uncertainty, partial shutdown of the business and low consumer confidence impacted demand organ-on-chip technology. The supply chain got hampered during the pandemic along with delay logistics activities. However, the organ-on-chip market is expected to regain its pace during the post-pandemic scenario due to the easing on the restrictions.
Global Organ-On-Chip Market Scope and Market Size
The organ-on-chip market is segmented on the basis of organ type, application, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Organ Type
- Liver
- Heart
- Lung
- Other Organ Types
Application
- Drug Discovery
- Toxicology Research
- Others
End User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Other
Organ-On-Chip Market Regional Analysis/Insights
The organ-on-chip market is analysed and market size insights and trends are provided by country, organ type, application, and end user as referred above.
The countries covered in the organ-on-chip market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, Israel, Egypt, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the organ-on-chip market because of the availability of an extensive array of assistance extended by significant market pros and an increment in the toxicological analysis of drugs on the distinct varieties of organ cells.
Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2022 to 2029 because of the adoption of advanced technology in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Organ-On-Chip Market
The organ-on-chip market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to organ-on-chip market.
Some of the major players operating in organ-on-chip market are
- AxoSim (US)
- BiomimX S.r.l. (Italy)
- Elveflow (France)
- Emulate, Inc. (US)
- Hµrel Corporation (US)
- InSphero (Switzerland)
- MIMETAS (Netherlands)
- NORTIS, INC. (US)
- TARA Biosystems, Inc. (US)
- Logo TissUse GmbH (Germany)
SKU-